VGX-3100

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Drug Information

Target Indication

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

INO

Inovio Pharmaceuticals, Inc.

Related Pipeline

Respiratory Papillomatosis

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Cervical Intraepithelial Neoplasia

Glioblastoma

Head and Neck Squamous Cell Cancer

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts